powered by MultiView

Medical & Allied Healthcare Exclusives

FDA issues public safety notification after exosome treatment sickens patients in Nebraska

FDA issues public safety notification after exosome treatment sickens patients in Nebraska

Friday, January 17, 2020

Last month, the Food and Drug Administration (FDA) issued a public safety notification regarding exosome products following multiple reports of serious adverse effects experienced by patients in Nebraska who received treatment with unapproved products…

Trending in Medical & Allied Healthcare
Recent Articles